1.	Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C) Phase: Phase IV Type: Treatment Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: H-2007-0252, PRMC_CO08303, NCT00994240
2.	Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: 30 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DUSA-PDT-BCC-06, DUSA-PDT-BCC-06, NCT00747903
3.	Trial Comparing the Effects of Intermittent Vismodegib Versus Photodynamic Therapy in Patients With Multiple Basal Cell Carcinomas Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2011-077, ML28244, NCT01556009
4.	Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes Phase: Phase II Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: ML28485, NCT01700049
5.	A Study of Two Vismodegib Regimens in Patients With Multiple Basal Cell Carcinomas Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MO28295, 2012-003305-10, NCT01815840
6.	A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: 54F28-001, NCT01608867
7.	Electronic Brachytherapy for the Treatment of NMSC Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 50 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTPR-0002, NCT01016899
8.	Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: IRB00012329, NCT01526486
9.	Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SKIN0009, SU-09022011-8371, 21759, NCT01529450
10.	Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer Phase: No phase specified Type: Treatment Status: Active Age: 35 to 90 Sponsor: Pharmaceutical / Industry Protocol IDs: MT-DMG-1, NCT01536444
11.	Vismodegib in Treating Patients With Basal Cell Carcinoma Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: SKIN0012, NCI-2012-01055, 24313, NCT01631331
12.	Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: SKIN0015, NCI-2013-00387, NCT01791894